JP2006515572A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006515572A5 JP2006515572A5 JP2004552920A JP2004552920A JP2006515572A5 JP 2006515572 A5 JP2006515572 A5 JP 2006515572A5 JP 2004552920 A JP2004552920 A JP 2004552920A JP 2004552920 A JP2004552920 A JP 2004552920A JP 2006515572 A5 JP2006515572 A5 JP 2006515572A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- branched
- linear
- hydrogen atom
- atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*(C)CCCN(CC*(C)(C)C)C(c1c[n]2c3c(*)c(*)c(*)c(*)c3c(***)c(*)c2n1)OC Chemical compound C*(C)CCCN(CC*(C)(C)C)C(c1c[n]2c3c(*)c(*)c(*)c(*)c3c(***)c(*)c2n1)OC 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0203976A HUP0203976A3 (en) | 2002-11-15 | 2002-11-15 | Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them |
| PCT/HU2003/000095 WO2004046146A1 (en) | 2002-11-15 | 2003-11-11 | Imidazoquinoline derivatives as adenosine a3 receptor ligands |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006515572A JP2006515572A (ja) | 2006-06-01 |
| JP2006515572A5 true JP2006515572A5 (https=) | 2006-09-14 |
| JP4533148B2 JP4533148B2 (ja) | 2010-09-01 |
Family
ID=90001561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004552920A Expired - Fee Related JP4533148B2 (ja) | 2002-11-15 | 2003-11-11 | アデノシンａ３受容体リガンドとしてのイミダゾキノリン誘導体 |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US7419977B2 (https=) |
| EP (1) | EP1560828B9 (https=) |
| JP (1) | JP4533148B2 (https=) |
| KR (1) | KR20050088291A (https=) |
| CN (1) | CN1332960C (https=) |
| AR (1) | AR041968A1 (https=) |
| AT (1) | ATE325123T1 (https=) |
| AU (1) | AU2003282263B2 (https=) |
| BR (1) | BR0316355A (https=) |
| CA (1) | CA2505910C (https=) |
| CO (1) | CO5690577A2 (https=) |
| CY (1) | CY1105180T1 (https=) |
| DE (1) | DE60305058T2 (https=) |
| DK (1) | DK1560828T3 (https=) |
| EA (1) | EA007595B1 (https=) |
| ES (1) | ES2263039T3 (https=) |
| HR (1) | HRP20050540A2 (https=) |
| HU (1) | HUP0203976A3 (https=) |
| IL (1) | IL168516A (https=) |
| IS (1) | IS2456B (https=) |
| MA (1) | MA27501A1 (https=) |
| ME (1) | MEP19008A (https=) |
| MX (1) | MXPA05005198A (https=) |
| NO (1) | NO20052866L (https=) |
| NZ (1) | NZ540029A (https=) |
| PL (1) | PL376837A1 (https=) |
| PT (1) | PT1560828E (https=) |
| RS (1) | RS51320B (https=) |
| SI (1) | SI1560828T1 (https=) |
| TN (1) | TNSN05133A1 (https=) |
| TW (1) | TWI248934B (https=) |
| UA (1) | UA78889C2 (https=) |
| WO (1) | WO2004046146A1 (https=) |
| ZA (1) | ZA200503807B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0105406A3 (en) * | 2001-12-21 | 2003-12-29 | Sanofi Aventis | Imidazo[1,2-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates |
| HUP0203976A3 (en) * | 2002-11-15 | 2004-08-30 | Sanofi Aventis | Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them |
| HUP0400812A2 (en) * | 2004-04-19 | 2006-02-28 | Sanofi Aventis | Crystalline forms of 2-amino-3-cyano-quinoline derivatives, process for their preparation and pharmaceutical compositions containing them |
| GT200600381A (es) | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
| US20090088403A1 (en) * | 2007-05-07 | 2009-04-02 | Randy Blakely | A3 adenosine receptors as targets for the modulation of central serotonergic signaling |
| HUP0700395A2 (en) * | 2007-06-07 | 2009-03-02 | Sanofi Aventis | Substituted [1,2,4] triazolo [1,5-a] quinolines, process for their preparation, pharmaceutical compositions thereof, and intermediates |
| WO2011010306A1 (en) | 2009-07-21 | 2011-01-27 | Ramot At Tel-Aviv University Ltd. | A3 adenosine receptor ligands for modulation of pigmentation |
| DK2950649T3 (da) | 2013-02-01 | 2020-05-04 | Wellstat Therapeutics Corp | Aminforbindelser med antiinflammations-, antisvampe-, antiparasit- og anticanceraktivitet |
| KR101820909B1 (ko) * | 2017-07-07 | 2018-01-23 | 퓨쳐메디신 주식회사 | 아데노신 유도체를 포함하는 만성신장질환 예방 및 치료용 약학적 조성물 |
| US11292791B2 (en) | 2017-09-15 | 2022-04-05 | Forma Therapeutics, Inc. | Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors |
| IL279734B2 (en) | 2018-06-29 | 2024-11-01 | Forma Therapeutics Inc | Inhibiting creb binding protein (cbp) |
| US12351577B2 (en) | 2019-03-15 | 2025-07-08 | Forma Therapeutics, Inc. | Inhibiting cyclic AMP-responsive element-binding protein (CREB) |
| EP3937936A4 (en) * | 2019-03-15 | 2022-12-28 | Forma Therapeutics, Inc. | INHIBITION OF CYCLIC AMP-RESPONSIVE ELEMENT-BINDING PROTEIN (CREB) |
| US11801243B2 (en) | 2020-09-23 | 2023-10-31 | Forma Therapeutics, Inc. | Bromodomain inhibitors for androgen receptor-driven cancers |
| US11795168B2 (en) | 2020-09-23 | 2023-10-24 | Forma Therapeutics, Inc. | Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4075343A (en) * | 1976-09-13 | 1978-02-21 | Pfizer Inc. | Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof |
| GB1596652A (en) * | 1977-01-20 | 1981-08-26 | Roussel Lab Ltd | Imidazo (1,2-a) quinoline-2-carboxylic acid and derivatives |
| IL59104A (en) * | 1979-02-09 | 1984-02-29 | Roussel Uclaf | Heterotricyclic derivatives,process for their preparation and pharmaceutical compositions incorporating them |
| FR2448541A1 (fr) * | 1979-02-09 | 1980-09-05 | Roussel Uclaf | Nouveaux derives de l'oxoimidazoquinoxaline et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
| US4644002A (en) * | 1979-02-09 | 1987-02-17 | Roussel Uclaf | Imidazo[2,1-C]quinolines, useful as antiallergic agents |
| AU4980999A (en) * | 1998-07-10 | 2000-02-01 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | A3 adenosine receptor antagonists |
| US6448253B1 (en) * | 1998-09-16 | 2002-09-10 | King Pharmaceuticals Research And Development, Inc. | Adenosine A3 receptor modulators |
| WO2001023391A1 (en) * | 1999-09-28 | 2001-04-05 | Otsuka Pharmaceutical Factory, Inc. | Triazolopurine derivatives, drug compositions containing the same and adenosine a3 receptor affinitive agents |
| US7160890B2 (en) * | 1999-12-02 | 2007-01-09 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
| AP1893A (en) * | 2000-12-01 | 2008-09-23 | Osi Pharm Inc | Compounds specific to adenosine A1, A2A and A3 receptor and uses thereof |
| KR100745307B1 (ko) * | 2001-05-31 | 2007-08-01 | 사노피-아벤티스 | 아미노퀴놀린 유도체 및 아데노신 ａ３ 리간드로서의 이의 용도 |
| HUP0105407A3 (en) * | 2001-12-21 | 2004-04-28 | Sanofi Aventis | Triazolo[1,5-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates |
| HUP0105406A3 (en) * | 2001-12-21 | 2003-12-29 | Sanofi Aventis | Imidazo[1,2-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates |
| HUP0203976A3 (en) | 2002-11-15 | 2004-08-30 | Sanofi Aventis | Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them |
-
2002
- 2002-11-15 HU HU0203976A patent/HUP0203976A3/hu unknown
-
2003
- 2003-11-11 PL PL376837A patent/PL376837A1/pl not_active Application Discontinuation
- 2003-11-11 HR HR20050540A patent/HRP20050540A2/xx not_active Application Discontinuation
- 2003-11-11 SI SI200330299T patent/SI1560828T1/sl unknown
- 2003-11-11 JP JP2004552920A patent/JP4533148B2/ja not_active Expired - Fee Related
- 2003-11-11 EP EP03773882A patent/EP1560828B9/en not_active Expired - Lifetime
- 2003-11-11 EA EA200500830A patent/EA007595B1/ru unknown
- 2003-11-11 CN CNB2003801062293A patent/CN1332960C/zh not_active Expired - Fee Related
- 2003-11-11 AU AU2003282263A patent/AU2003282263B2/en not_active Ceased
- 2003-11-11 MX MXPA05005198A patent/MXPA05005198A/es active IP Right Grant
- 2003-11-11 DE DE60305058T patent/DE60305058T2/de not_active Expired - Lifetime
- 2003-11-11 RS YUP-2005/0364A patent/RS51320B/sr unknown
- 2003-11-11 ES ES03773882T patent/ES2263039T3/es not_active Expired - Lifetime
- 2003-11-11 PT PT03773882T patent/PT1560828E/pt unknown
- 2003-11-11 BR BR0316355-5A patent/BR0316355A/pt not_active IP Right Cessation
- 2003-11-11 KR KR1020057008683A patent/KR20050088291A/ko not_active Abandoned
- 2003-11-11 WO PCT/HU2003/000095 patent/WO2004046146A1/en not_active Ceased
- 2003-11-11 ME MEP-190/08A patent/MEP19008A/xx unknown
- 2003-11-11 CA CA2505910A patent/CA2505910C/en not_active Expired - Fee Related
- 2003-11-11 AT AT03773882T patent/ATE325123T1/de active
- 2003-11-11 UA UAA200505875A patent/UA78889C2/uk unknown
- 2003-11-11 DK DK03773882T patent/DK1560828T3/da active
- 2003-11-11 NZ NZ540029A patent/NZ540029A/en not_active IP Right Cessation
- 2003-11-14 AR ARP030104200A patent/AR041968A1/es unknown
- 2003-11-14 TW TW092131901A patent/TWI248934B/zh not_active IP Right Cessation
-
2005
- 2005-05-10 TN TNP2005000133A patent/TNSN05133A1/en unknown
- 2005-05-10 IL IL168516A patent/IL168516A/en not_active IP Right Cessation
- 2005-05-11 ZA ZA200503807A patent/ZA200503807B/en unknown
- 2005-05-16 US US11/130,429 patent/US7419977B2/en not_active Expired - Fee Related
- 2005-05-31 IS IS7874A patent/IS2456B/is unknown
- 2005-06-13 MA MA28334A patent/MA27501A1/fr unknown
- 2005-06-13 NO NO20052866A patent/NO20052866L/no not_active Application Discontinuation
- 2005-06-14 CO CO05057645A patent/CO5690577A2/es not_active Application Discontinuation
-
2006
- 2006-07-28 CY CY20061101054T patent/CY1105180T1/el unknown
-
2008
- 2008-06-17 US US12/140,512 patent/US7709489B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006515572A5 (https=) | ||
| JP7787063B2 (ja) | オーロラキナーゼ阻害剤およびその使用 | |
| US6391872B1 (en) | Indazole bioisostere replacement of catechol in therapeutically active compounds | |
| DE69108138T2 (de) | Imidazopyridinderivate und ihre Verwendung. | |
| JP4714686B2 (ja) | 新規のγ−セクレターゼ阻害剤 | |
| KR101921404B1 (ko) | 신규 2치환 1,2,4-트리아진 화합물 | |
| JP3176935B2 (ja) | ドーパミンリセプタサプタイプ特異性リガンドとしてのｎ―アミノアルキルジベンゾフランカルボキサミド | |
| EP3034500A1 (en) | Amido thiazole derivatives as NADPH oxidase inhibitors | |
| HRP20041005A2 (en) | Quinoline and isoquinoline derivatives, method forthe production thereof and use thereof as anti-inflammatory agents | |
| EP3227270A2 (en) | Heterocyclic derivatives and use thereof | |
| JP2011520954A (ja) | フェニルまたはピリジニル置換インダゾール誘導体 | |
| EP2023728A2 (en) | Oxazolyl piperidine modulators of fatty acid amide hydrolase | |
| JP2005505618A5 (https=) | ||
| JP2011510004A (ja) | タンパク質キナーゼ阻害剤及びその使用 | |
| EP2107054A1 (en) | Antiproliferative compounds and therapeutic uses thereof | |
| CA2681972A1 (en) | Substituted dibenzoic acid derivatives and use thereof | |
| RU2009149518A (ru) | Триазоло[1, 5-а]хинолины в качестве лигандов рецептора аденозина а3 | |
| EA022473B1 (ru) | Производные 5-циано-2-амино-1,3-тиазола в качестве антагонистов аденозинового арецептора | |
| CZ20001136A3 (cs) | Tetracyklické deriváty tetrahydrofuranu substituované halogenem, způsob jejich přípravy a jejich použití pro přípravu léčiv | |
| CA2505910A1 (en) | Imidazoquinoline derivatives as adenosine a3 receptor ligands | |
| CN106795152B (zh) | 蛋白激酶抑制剂 | |
| JP2007503432A5 (https=) | ||
| JP2005516956A5 (https=) | ||
| BR112016001238B1 (pt) | Derivados de 1-(piperazin-1-il)-2-([1,2,4]triazol-1-il)-etanona, seus usos e composição farmacêutica os compreendendo | |
| US10202401B2 (en) | Process for making tetracyclic heterocycle compounds |